Therapeutic monitoring of biologics: on the way to personalized medicine

Czech version

Authors: K. Černá
Authors‘ workplace: Klinické a výzkumné centrum pro střevní záněty, Klinické centrum ISCARE a. s. a 1. LF UK v Praze
Published in: Gastroent Hepatol 2023; 77(1): 64-65
Category:

Labels

Paediatric gastroenterology Gastroenterology and hepatology Surgery

Biological therapy of ulcerative colitis during pregnancy

Complicated course of IBD in pregnancy

On the question of the interchangeability of monoclonal bio similar antibodies in the treatment of immune-mediated infl ammatory diseases

Gastrointestinal dysfunctions and their influence on the quality of life in aging adults with spinal cord injury

Autoimmune hepatitis after vaccination against COVID-19

The selection from international journals

Fatal course of an infl ammatory disease

Two years of the COVID-19 pandemic in the population of Czech patients with infl ammatory bowel disease treated with bio logical therapy – experience of the tertiary IBD center

Primary signet ring cell adenocarcinoma as a rare cause of colonic stenosis in a young patient with Crohn’s disease – the case report

Editorial

Epidemiological and demographic characteristics of individuals with irritable bowel syndrome based on the Rome III vs. Rome IV criteria in the Northern part of Serbia

Editorial

17th educational and discussion gastroenterology days

Professor Ryska has passed away, his legacy remains

Assoc. Prof. Igor Kajaba, MD, PhD.

Kreditovaný autodidaktický test

Overview of the most common skin adverse reactions of biological treatment in patients with inflammatory bowel disease – part 1

Tofacitinib – is it time for a change in treatment in ulcerative colitis?

Article was published in

Gastroenterology and Hepatology

2023 Issue 1

Therapeutic monitoring of bio­logics: on the way to personalized medicine

Labels

Gastroenterology and Hepatology

Therapeutic monitoring of biologics: on the way to personalized medicine